IDENTIFY
The Patient and Current Regimen
Carry forward the same patient from TruTYPE and TruRISK with the prioritized findings.
- Fluoxetine 60 mg daily
- Omeprazole 20 mg daily
- Clopidogrel 75 mg daily
- Hydrocodone 5/325 mg PRN
- Irbesartan 150 mg daily
TruSELECT® integrates the patient’s functional PK environment, prioritized medication risks and published guidance to identify alternative options for the provider to evaluate before changing or adding new medication therapy.
✓ Do the clinical symptoms fit the risk?
✓ Which option best fits the BluPRINTRx®?
✓ Alternative options for the provider to evaluate before changing or adding new medication therapy.
One Patient.
One Personalized Medication Picture.
One BluPRINTRx®.
Carry forward the same patient from TruTYPE and TruRISK with the prioritized findings.
Changing one medication can affect multiple drugs. Know how an alternative is processed and the traffic it may cause for other medications, FIRST.
Review medication-specific FDA and ClinPGx/CPIC guidance in the same patient context.
Evaluate alternative options before changing or adding therapy—and see how each option may affect the entire BluPRINTRx®.
Changing one medication can affect multiple drugs. See how an alternative is processed and the traffic it may cause for other medications, FIRST.
Evaluate citalopram, escitalopram and desvenlafaxine and compare how each option changes the patient-specific medication environment.
Review evidence-supported options including continue/monitor, dose or timing considerations, alternative therapy and additional information.
Know how it is processed and the traffic it may cause for other medications, FIRST.